Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors

Published:2020-06 Issue: Volume:17 Page:47-60
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Cervera-Carrascon Victor,Quixabeira Dafne C.A.,Havunen Riikka,Santos Joao M.,Kutvonen Emma,Clubb James H.A.,Siurala Mikko,Heiniö Camilla,Zafar Sadia,Koivula Teija,Lumen Dave,Vaha Marjo,Garcia-Horsman Arturo,Airaksinen Anu J.,Sorsa Suvi,Anttila Marjukka,Hukkanen Veijo,Kanerva Anna,Hemminki Akseli

Funder

Marie Skłodowska-Curie Innovative Training Networks

Jane and Aatos Erkko Foundation

HUCH Research Funds

Sigrid Juselius Foundation

Finnish Cancer Organizations

University of Helsinki

TILT Biotherapeutics

Novo Nordisk Foundation

Päivikki and Sakari Sohlberg Foundation

Finnish Society of Sciences and Letters

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference73 articles.

1. History of oncolytic viruses: genesis to genetic engineering;Kelly;Mol. Ther.,2007

2. Oncolytic Viruses: Exploiting Cancer’s Deal with the Devil;Pikor;Trends Cancer,2015

3. Studies in Hodgkin’s syndrome; the association of viral hepatitis and Hodgkin’s disease; a preliminary report;Hoster;Cancer Res.,1949

4. Studies on the use of viruses in the treatment of carcinoma of the cervix;Huebner;Cancer,1956

5. Clinical studies of viruses as antineoplastic agents with particular reference to Egypt 101 virus;Southam;Cancer,1952

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonclinical characterization of ICVB-1042 as a selective oncolytic adenovirus for solid tumor treatment;Communications Biology;2024-09-13

2. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy;Nature Protocols;2024-05-20

3. Engineering Microorganisms for Cancer Immunotherapy;Advanced Healthcare Materials;2024-04-21

4. Long-term antigen-specific immune response by an oncolytic adenovirus encoding SP-SA-E7-4-1BBL in HPV-16 cancer model;Molecular Biology Reports;2024-03-09

5. Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy;Molecular Therapy;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3